Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Nowak

Showing results (291-300 of 306) with videos related to

Pageof 31
Sort By:
Endocrinology|December 29, 2007
Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathwayEva Göncz, Mathias Z Strowski, Carsten Grötzinger, et al.
Hepato-Gastroenterology|July 21, 2001
IGF-I triple helix strategy in hepatoma treatmentL C Upegui-Gonzalez, A Ly, M Sierzega, et al.
Polish Journal of Pharmacology|December 14, 2004
Effect of topiramate on the kainate-induced status epilepticus, lipid peroxidation and immunoreactivity of ratsM Kubera, B Budziszewska, L Jaworska-Feil, et al.
Diabetologia|April 21, 2011
Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytesM Skrzypski, T T Le, P Kaczmarek, et al.
Nanotechnology|June 25, 2009
Intracellular nanomanipulation by a photonic-force microscope with real-time acquisition of a 3D stiffness matrixE Bertseva, A S G Singh, J Lekki, et al.
Regulatory Peptides|June 2, 2009
Insulinostatic activity of cerebellin--evidence from in vivo and in vitro studies in ratsMathias Z Strowski, Przemyslaw Kaczmarek, Stefan Mergler, et al.
Endocrinology|May 26, 2007
Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen depositionVandana Singh, Carsten Grötzinger, Krzysztof W Nowak, et al.
Diabetologia|December 25, 2012
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?A M Arafat, P Kaczmarek, M Skrzypski, et al.
Endocrinology|July 22, 2006
Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonistMathias Z Strowski, Doreen E Cashen, Elizabeth T Birzin, et al.
Diabetologia|July 27, 2014
Glucagon regulates orexin A secretion in humans and rodentsAyman M Arafat, Przemysław Kaczmarek, Marek Skrzypski, et al.
Pageof 31

Showing results (291-300 of 306) with videos related to

Sort By:
Pageof 31
Endocrinology|December 29, 2007
Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathwayEva Göncz, Mathias Z Strowski, Carsten Grötzinger, et al.
Hepato-Gastroenterology|July 21, 2001
IGF-I triple helix strategy in hepatoma treatmentL C Upegui-Gonzalez, A Ly, M Sierzega, et al.
Polish Journal of Pharmacology|December 14, 2004
Effect of topiramate on the kainate-induced status epilepticus, lipid peroxidation and immunoreactivity of ratsM Kubera, B Budziszewska, L Jaworska-Feil, et al.
Diabetologia|April 21, 2011
Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytesM Skrzypski, T T Le, P Kaczmarek, et al.
Nanotechnology|June 25, 2009
Intracellular nanomanipulation by a photonic-force microscope with real-time acquisition of a 3D stiffness matrixE Bertseva, A S G Singh, J Lekki, et al.
Regulatory Peptides|June 2, 2009
Insulinostatic activity of cerebellin--evidence from in vivo and in vitro studies in ratsMathias Z Strowski, Przemyslaw Kaczmarek, Stefan Mergler, et al.
Endocrinology|May 26, 2007
Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen depositionVandana Singh, Carsten Grötzinger, Krzysztof W Nowak, et al.
Diabetologia|December 25, 2012
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?A M Arafat, P Kaczmarek, M Skrzypski, et al.
Endocrinology|July 22, 2006
Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonistMathias Z Strowski, Doreen E Cashen, Elizabeth T Birzin, et al.
Diabetologia|July 27, 2014
Glucagon regulates orexin A secretion in humans and rodentsAyman M Arafat, Przemysław Kaczmarek, Marek Skrzypski, et al.
Pageof 31